Novel Protein Footprinting Technology for Reproducible HRPF Experiments
Novel Protein Footprinting Technology for Reproducible HRPF Experiments May 24 2021 GenNext Technologies, Inc, a growth-stage company that provides instrumentation, software, and services to structural biology researchers within the biopharmaceutical industry, announced today that nearly US$7 million in NIH grant awards has led to a seminal US patent for its novel technology that vastly improves the utility of protein footprinting for the study of biopharmaceutical higher order ...
United States Scotr Weinberger Trademark Office National Institute Gennext Technologies Inc Gennext Technologies
Source: labmate-online.com